ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    INCB 18424-258
Previous Study | Return to List | Next Study

Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01348490
Recruitment Status : Active, not recruiting
First Posted : May 5, 2011
Last Update Posted : April 4, 2018
Sponsor:
Information provided by (Responsible Party):
Incyte Corporation